drugset / Trial / NCT01434134

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy

NCT01434134

RandomizedFactorialQuadruple-blindPrevention

Summary

Women treated for breast cancer are at increased risk for cardiovascular disease, including heart failure. In this study, by using magnetic resonance imaging (MRI), the investigators want to assess if heart failure medications such as beta blockers and angiotensin receptor blockers can prevent cardiac dysfunction during early breast cancer therapy.

Timeline

Start
2011-09
Primary completion
2014-09
Completion
2014-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Candesartan Unknown 32 mg
Subject Metoprolol Other / unclassified 100 mg